Autosomal Dominant Retinitis Pigmentosa
method(s): ◦ Sequencing, Next Gen
Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
NR2E3 Sequence Analysis
method(s): ◦ Sequencing, Capillary (Sanger)
Baylor Miraca Genetics Laboratories - Houston, TX, USA |
NR2E3 Familial Mutation/Variant Analysis
method(s): ◦ Sequencing, Capillary (Sanger)
Baylor Miraca Genetics Laboratories - Houston, TX, USA |
NR2E3 Prenatal Sequence Analysis
method(s): ◦ Sequencing, Capillary (Sanger)
Baylor Miraca Genetics Laboratories - Houston, TX, USA |
Eye Disorders: Comprehensive Sequencing and Deletion/Duplication Panel
method(s):
Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
Retinitis Pigmentosa: Sequencing and Deletion/Duplication Panel
method(s):
Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
adRP mutation detection in 15 genes: CA4, FSCN2, IMPDH1, NRL, PPF3, PRPF31, PRPF8, RDS, RHO, ROM1, RP1, RP9, CRX , TOPORS and PNR
method(s): ◦ Genotyping (Microarray, Beads, etc.)
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
arRP mutation detection in 28 genes: CERKL, CNGA1, CNGB1, MERTK, PDE6A, PDE6B, NR2E3, RDH12, RGR, RLBP1, SAG, TULP1, CRB1, RPE65, USH2A, CLRN1, LRAT, PROM1, RBP3, EYS, ABCA4, AIPL1, CNGA3, CNGB3, GRK1, IMPG2, RHO, and RP1
method(s): ◦ Genotyping (Microarray, Beads, etc.)
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 20 genes: ABCA4, BEST1, CA4, FSCN2, GUCA1B, IMPDH1, KLHL7, NR2E3, NRL, RGR, RP1, RHO, RP9, PRPF3, PRPF8, PRPH2, PRPF31, SEMA4A, SNRNP200, TOPORS
method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 28 genes, ABCA4, ARL6, C2orf71, CERKL, CNGA1, CNGB1, CRB1, EYS, IDH3B, IMPG2, MERTK, NR2E3, PDE6A, PDE6B, PDE6G, PRCD, PROM1, RDH12, RGR, RHO, RP1, RPE65, SAG, SEMA4A, TTC8, TULP1, USH2A, ZNF513
method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NR2E3 Gene Sequencing
method(s): ◦ Sequencing, Capillary (Sanger)
GeneDx - Gaithersburg, MD, USA |
Autosomal Recessive Retinitis Pigmentosa
method(s): ◦ Sequencing, Next Gen
Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
Enhanced S-Cone
method(s): ◦ Genotyping (Microarray, Beads, etc.)
Recombine - Livingston, NJ, USA |
Retinitis Pigmentosa Type 37, Sequencing NR2E3 Gene
method(s): ◦ Sequencing, Capillary (Sanger)
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Autosomal Recessive and Sporadic Retinitis Pigmentosa, Panel Massive Sequencing (NGS) 41 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Autosomal Dominant Retinitis Pigmentosa, Panel Massive Sequencing (NGS) 27 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Retinitis Pigmentosa/Leber Congenital Amaurosis Panel, Sequencing and Deletion/Duplication, 53 Genes
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Eye Diseases Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Retinitis pigmentosa type 37 (sequence analysis of NR2E3 gene)
method(s): ◦ Sequencing, Capillary (Sanger)
CGC Genetics - Porto, Portugal |
Retinitis pigmentosa, AR (NGS panel for AIPL1, BEST1, CA4, CRX, GUCA1B, FSCN2, IMPDH1, KLHL7, NR2E3, NRL, PRPF3, PRPF6, PRPF8, PRPF31, PRPH2, RDH12, RGR, RHO, ROM1, RP1, RP9, RPE65, SEMA4A, SNRNP200 and TOPORS genes)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
TAT: 4-8 weeks
price: $635.00
Analysis NR2E3 gene (Enhanced S Cone Syndrome, Retinitis Pigmentosa 37)
method(s): ◦ Sequencing, Capillary (Sanger)
Academic Medical Centre, University of Amsterdam, DNA Diagnostics Laboratory - Amsterdam, Netherlands |
Gedi-R, Genetic Eye Disease Panel for Retinal Genes
method(s): ◦ Sequencing, Next Gen
Ocular Genomics Institute Genetic Diagnostic Laboratory at Massachusetts Eye and Ear Infirmary - Boston, MA, USA |
Retinitis Pigmentosa A.R.
method(s): ◦ Sequencing, Next Gen
GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Retinitis Pigmentosa A.D
method(s): ◦ Sequencing, Next Gen
GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Retinitis Pigmentosa, Autosomal Dominant and X-Linked Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Retinitis Pigmentosa, Autosomal Recessive and X-Linked Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Retinitis pigmentosa (NGS panel for 55 genes)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
Retinitis pigmentosa, AR and X-linked (NGS panel for 54 genes)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
Retinitis pigmentosa, AD and X-linked (NGS panel for 27 genes)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
Single gene testing NR2E3
method(s): ◦ Sequencing, Capillary (Sanger)
CeGaT GmbH - Tübingen, Germany |
Eye Disorders: Comprehensive Sequencing Panel
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Eye Disorders: Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Retinitis Pigmentosa (Complete Panel), Panel Massive Sequencing (NGS) 57 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Retina/Photoreceptor Dystrophy: Sequencing Panel
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Retina/Photoreceptor Dystrophy: Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Retinitis Pigmentosa: Sequencing Panel
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Retinitis Pigmentosa: Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Eye Disorders NGS Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
Fulgent Diagnostics - Temple City, CA, USA |
NR2E3
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Fulgent Diagnostics - Temple City, CA, USA |
Retinitis Pigmentosa NGS Panel
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Fulgent Diagnostics - Temple City, CA, USA |
Horizon 106 (Comprehensive Jewish Panel)
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
Natera, Inc. - San Carlos, CA, USA |
Horizon 274 (Pan-Ethnic Extended Panel)
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
Natera, Inc. - San Carlos, CA, USA |
TAT: 3-4 weeks
price: $690.00
Retinitis Pigmentosa via the NR2E3 Gene
method(s): ◦ Del/Dup (CNV)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-4 weeks
price: $1,290.00
Autosomal Dominant Retinitis Pigmentosa Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-4 weeks
price: $1,670.00
Autosomal Recessive Retinitis Pigmentosa Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-4 weeks
price: $1,670.00
Retinitis Pigmentosa Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 2-3 weeks
price: $650.00
Retinitis Pigmentosa via the NR2E3 Gene
method(s): ◦ Sequencing, Capillary (Sanger)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks
price: $1,840.00
Autosomal Dominant Retinitis Pigmentosa Sequencing Panel
method(s): ◦ Sequencing, Next Gen
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks
price: $2,240.00
Autosomal Recessive Retinitis Pigmentosa Sequencing Panel
method(s): ◦ Sequencing, Next Gen
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks
price: $2,890.00
Retinitis Pigmentosa (includes RPGR ORF15) Sequencing Panel
method(s): ◦ Sequencing, Next Gen
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
Retinitis pigmentosa (Retinitis pigmentosa)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Retinoschisis (Retinoschisis)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Goldmann-Favre Syndrome, Sequencing NR2E3
method(s): ◦ Sequencing, Capillary (Sanger)
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
TAT: 3-5 weeks
price: $2,390.00
Comprehensive Inherited Retinal Dystrophies (includes RPGR ORF15) Sequencing Panel
method(s): ◦ Sequencing, Next Gen
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-4 weeks
price: $1,990.00
Comprehensive Inherited Retinal Dystrophies Deletion/Duplication Panel
method(s): ◦ Del/Dup (CNV)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
Retinitis pigmentosa type 37, autosomal dominant/recessive
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Centogene AG, Rare Disease Company - Rostock, Germany |
TAT: 2-4 weeks
price: $1,490.00
Vitreoretinopathy NGS panel
method(s): ◦ Sequencing, Next Gen
Connective Tissue Gene Tests - Allentown, PA, USA |
TAT: 2-4 weeks
price: $1,150.00
Vitreoretinopathy NGS panel
method(s): ◦ Del/Dup (CNV)
Connective Tissue Gene Tests - Allentown, PA, USA |
TAT: 2-4 weeks
price: $2,490.00
Vitreoretinopathy NGS panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Connective Tissue Gene Tests - Allentown, PA, USA |
Retinitis pigmentosa panel, autosomal dominant
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
Retinitis pigmentosa panel, autosomal recessive
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
Retinal Dystrophy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Retinitis Pigmentosa Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Vitreoretinopathy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Retinal Dystrophy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Retinitis Pigmentosa Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Vitreoretinopathy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Eye Diseases Comprehensive Panel
method(s): ◦ Sequencing, Next Gen
Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
